AroCell AB Cash Flow Conversion Efficiency

Latest as of March 2025: -0.010x

AroCell AB cash flow conversion efficiency. Based on the latest financial reports, AroCell AB (AROC) has a cash flow conversion efficiency ratio of -0.010x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.11 Million ≈ $-119.67K USD) by net assets (Skr108.87 Million ≈ $11.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AroCell AB (AROC) market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of AroCell AB (2011–2024)

Cash flow conversion efficiency of AroCell AB from 2011 to 2024. This chart illustrates how AroCell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AroCell AB stock price for real-time trading data and today's change.

AroCell AB Cash Flow Conversion Ratio Explained

AroCell AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

AroCell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AroCell AB ranked by their cash flow conversion efficiency. Review how much free cash does AroCell AB generate to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Pasinex Resources Limited F:PNX	-0.047x
Imugene Ltd AU:IMU	-0.620x
All In! Games S.A. WAR:ALG	-0.028x
Destinasi Tirta Nusantara Tbk JK:PDES	0.250x
Tae Won Mulsan KO:001420	0.012x
Star Combo Pharma Ltd AU:S66	0.015x
Mynd.ai, Inc. NYSE MKT:MYND	-0.360x
CNFinance Holdings Ltd NYSE:CNF	-0.012x

Annual Cash Flow Conversion Efficiency for AroCell AB (2011–2024)

The table below shows the annual cash flow conversion efficiency of AroCell AB from 2011 to 2024. Also see AroCell AB total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr121.20 Million ≈ $13.04 Million	Skr-2.36 Million ≈ $-253.76K	-0.019x	+76.30%
2023-12-31	Skr163.65 Million ≈ $17.61 Million	Skr-13.44 Million ≈ $-1.45 Million	-0.082x	-33.52%
2022-12-31	Skr222.69 Million ≈ $23.97 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.061x	+52.59%
2021-12-31	Skr217.45 Million ≈ $23.40 Million	Skr-28.21 Million ≈ $-3.04 Million	-0.130x	+61.39%
2020-12-31	Skr56.26 Million ≈ $6.05 Million	Skr-18.90 Million ≈ $-2.03 Million	-0.336x	-79.44%
2019-12-31	Skr80.41 Million ≈ $8.65 Million	Skr-15.06 Million ≈ $-1.62 Million	-0.187x	+37.79%
2018-12-31	Skr54.51 Million ≈ $5.87 Million	Skr-16.41 Million ≈ $-1.77 Million	-0.301x	+7.78%
2017-12-31	Skr46.68 Million ≈ $5.02 Million	Skr-15.24 Million ≈ $-1.64 Million	-0.326x	-188.96%
2016-12-31	Skr63.46 Million ≈ $6.83 Million	Skr-7.17 Million ≈ $-771.34K	-0.113x	+10.05%
2015-12-31	Skr72.69 Million ≈ $7.82 Million	Skr-9.13 Million ≈ $-982.27K	-0.126x	+76.77%
2011-12-31	Skr4.80 Million ≈ $516.22K	Skr-2.59 Million ≈ $-279.05K	-0.541x	--

About AroCell AB

ST:AROC Sweden Diagnostics & Research

Market Cap

$13.39 Million

Skr124.39 Million SEK

Market Cap Rank

#26215 Global

#539 in Sweden

Share Price

Skr0.54

Change (1 day)

+0.00%

52-Week Range

Skr0.54 - Skr0.54

All Time High

Skr15.05